- 专利标题： Pyrimidines as PLK inhibitors
-
申请号： US11206703申请日： 2005-08-17
-
公开(公告)号： US20060148800A1公开(公告)日： 2006-07-06
- 发明人: Heinz Stadtmueller , Harald Engelhardt , Martin Steegmaier , Anke Baum , Ulrich Guertler , Andreas Schoop , Jen Quant , Flavio Solca , Rudolf Hauptmann , Ulrich Reiser , Stephan Zahn , Lars Herfurth
- 申请人： Heinz Stadtmueller , Harald Engelhardt , Martin Steegmaier , Anke Baum , Ulrich Guertler , Andreas Schoop , Jen Quant , Flavio Solca , Rudolf Hauptmann , Ulrich Reiser , Stephan Zahn , Lars Herfurth
- 申请人地址： DE Ingelheim
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim
- 优先权： EP04019775 20040820
- 主分类号： A61K31/53
- IPC分类号： A61K31/53
摘要：
The present invention encompasses compounds of general formula (1), wherein A, W, X, Y, Z, Ra, Rb, Rc, R1 and R3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.
公开/授权文献
- US07521457B2 Pyrimidines as PLK inhibitors 公开/授权日：2009-04-21
信息查询
